BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 37643427)

  • 21. A novel direction modulated brachytherapy technique for urethra sparing in high-dose-rate brachytherapy of prostate cancer.
    Meftahi M; Qiu RLJ; Patel P; Song WY; Yang X
    Radiother Oncol; 2023 Sep; 186():109801. PubMed ID: 37423478
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Practically achievable maximum high-risk clinical target volume doses in MRI-guided intracavitary brachytherapy for cervical cancer: a planning study.
    Menon G; Huang F; Sloboda R; Pearcey R; Ghosh S
    Brachytherapy; 2014; 13(6):572-8. PubMed ID: 25085455
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effectiveness of Rotating Shield Brachytherapy for Prostate Cancer Dose Escalation and Urethral Sparing.
    Adams Q; Hopfensperger KM; Kim Y; Wu X; Xu W; Shukla H; McGee J; Caster JM; Flynn RT
    Int J Radiat Oncol Biol Phys; 2018 Dec; 102(5):1543-1550. PubMed ID: 30092333
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dosimetric impact of a robust optimization approach to mitigate effects from rotational uncertainty in prostate intensity-modulated brachytherapy.
    Morén B; Antaki M; Famulari G; Morcos M; Larsson T; Enger SA; Tedgren ÅC
    Med Phys; 2023 Feb; 50(2):1029-1043. PubMed ID: 36478226
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A novel two-step optimization method for tandem and ovoid high-dose-rate brachytherapy treatment for locally advanced cervical cancer.
    Sharma M; Fields EC; Todor DA
    Brachytherapy; 2015; 14(5):613-8. PubMed ID: 26092424
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stability of Intracavitary Applicator Placement for HDR Brachytherapy of Cervix Cancer.
    Balsdon A; Timotin E; Hunter R; Diamond K
    J Med Imaging Radiat Sci; 2019 Sep; 50(3):441-448. PubMed ID: 31311722
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plan optimization with L0-norm and group sparsity constraints for a new rotational, intensity-modulated brachytherapy for cervical cancer.
    Kim H; Lim YK; Goh Y; Jeong C; Hwang UJ; Choi SH; Cho B; Kwak J
    PLoS One; 2020; 15(7):e0236585. PubMed ID: 32722692
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical outcomes of conventional HDR intracavitary brachytherapy combined with complementary applicator-guided intensity modulated radiotherapy boost in patients with bulky cervical tumour.
    Lu S; Wang S; Kim RY; Zhang J; Wang X; Wang W; Zhu G; Zhou J; Tan Y; Tan M; Li M; Yin G; Li J; Feng M; Lang J
    BJOG; 2023 Jan; 130(2):231-237. PubMed ID: 36330947
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Can MRI-only replace MRI-CT planning with a titanium tandem and ovoid applicator?
    Harkenrider MM; Patel R; Surucu M; Chinsky B; Mysz ML; Wood A; Ryan K; Shea SM; Small W; Roeske JC
    Brachytherapy; 2018; 17(5):747-752. PubMed ID: 29945764
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intensity-modulated brachytherapy for vaginal cancer.
    Joya M; Nedaie HA; Geraily G; Seiri M; Ghorbani M; Sheikhzadeh P
    Radiol Phys Technol; 2022 Dec; 15(4):387-397. PubMed ID: 36069978
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Consequences of random and systematic reconstruction uncertainties in 3D image based brachytherapy in cervical cancer.
    Tanderup K; Hellebust TP; Lang S; Granfeldt J; Pötter R; Lindegaard JC; Kirisits C
    Radiother Oncol; 2008 Nov; 89(2):156-63. PubMed ID: 18692265
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reporting and validation of gynaecological Groupe Euopeen de Curietherapie European Society for Therapeutic Radiology and Oncology (ESTRO) brachytherapy recommendations for MR image-based dose volume parameters and clinical outcome with high dose-rate brachytherapy in cervical cancers: a single-institution initial experience.
    Mahantshetty U; Swamidas J; Khanna N; Engineer R; Merchant NH; Deshpande DD; Shrivastava S
    Int J Gynecol Cancer; 2011 Aug; 21(6):1110-6. PubMed ID: 21633296
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Utrecht Interstitial Applicator Shifts and DVH Parameter Changes in 3D CT-based HDR Brachytherapy of Cervical Cancer.
    Shi D; He MY; Zhao ZP; Wu N; Zhao HF; Xu ZJ; Cheng GH
    Asian Pac J Cancer Prev; 2015; 16(9):3945-9. PubMed ID: 25987066
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical transition to model-based dose calculation algorithm: A retrospective analysis of high-dose-rate tandem and ring brachytherapy of the cervix.
    Jacob D; Lamberto M; DeSouza Lawrence L; Mourtada F
    Brachytherapy; 2017; 16(3):624-629. PubMed ID: 28365083
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of offline adaptive planning techniques in image-guided brachytherapy of cervical cancer.
    Liu H; Kinard J; Maurer J; Shang Q; Vanderstraeten C; Hayes L; Sintay B; Wiant D
    J Appl Clin Med Phys; 2018 Nov; 19(6):316-322. PubMed ID: 30284370
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of 2D vs. 3D dosimetry for Rotte 'Y' applicator high dose rate brachytherapy for medically inoperable endometrial cancer.
    Beriwal S; Kim H; Heron DE; Selvaraj R
    Technol Cancer Res Treat; 2006 Oct; 5(5):521-7. PubMed ID: 16981795
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Commissioning of a grid-based Boltzmann solver for cervical cancer brachytherapy treatment planning with shielded colpostats.
    Mikell JK; Klopp AH; Price M; Mourtada F
    Brachytherapy; 2013; 12(6):645-53. PubMed ID: 23891341
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Direction modulated brachytherapy (DMBT) tandem applicator for cervical cancer treatment: Choosing the optimal shielding material.
    Safigholi H; Han DY; Soliman A; Song WY
    Med Phys; 2018 Jun; ():. PubMed ID: 29858499
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical feasibility of interstitial brachytherapy using a "hybrid" applicator combining uterine tandem and interstitial metal needles based on CT for locally advanced cervical cancer.
    Liu ZS; Guo J; Lin X; Wang HY; Qiu L; Ren XJ; Li YF; Zhang BY; Wang TJ
    Brachytherapy; 2016; 15(5):562-9. PubMed ID: 27474180
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Attention 3D U-NET for dose distribution prediction of high-dose-rate brachytherapy of cervical cancer: Direction modulated brachytherapy tandem applicator.
    Gautam S; Osman AFI; Richeson D; Gholami S; Manandhar B; Alam S; Song WY
    Med Phys; 2024 Jun; ():. PubMed ID: 38830129
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.